MacroGenics | MGNX - 負債

株価
3.60
毎日の変更
0.16 4.65%
毎月
7.78%
毎年
179.07%
Q2 予測
3.50




負債 変化する 日付
AbbVie USD 1000K 70.48B 2025-09
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Biogen USD 6.29B 1.7M 2025-12
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Genmab DKK 148M 5M 2025-06
Geron USD 121.92M 73K 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
J&J USD 45.8B 4.97B 2025-09
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 37.01M 238K 2025-09
Merck USD 41.37B 5.97B 2025-09
Pfizer USD 60.85B 78M 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Xencor USD 69.27M 1.34M 2025-09